Advances in RNAi--A Global Technology Assessment (Technical Insights)

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

This research service tracks and analyzes recent RNAi technology development, globally.

Table of Contents

Advances in RNAi--A Global Technology Assessment (Technical Insights), Executive SummaryIntroductionRNAi Technology in BriefOverview of the RNAi SectorScope and MethodologyResearch ScopeResearch MethodologyAdvances in RNAi--A Global Technology Assessment (Technical Insights), Research Developments in RNAi DesignResearch in the Private SectorThe Silencer Effect (USA)DNA-Based siRNA Constructs (USA)Novel RNAi Expression Cassettes (USA)Increase RNAi Stability by Chemical Modifications (Belgium)Research in the Public SectorInhibit More Genes Simultaneously (USA)Take the siDirect Approach (Japan)UMMS Provides Exclusive RNAi Technologies (USA)Advances in RNAi--A Global Technology Assessment (Technical Insights), Research Developments in RNAi DeliveryResearch in the Private SectorExplore Electroporation for Efficient RNAi Delivery (Germany)Mouse Musings–Development of RNAi Knockdown in Mice (Germany)Novel Lipid and Polymer-Based Transfection Reagents (USA)Adenoviral siRNA Library (Belgium)Electroporation for Vascular Gene Therapy (USA)Research in the Public SectorResearch Liposome Technology as Delivery Vehicles (Netherlands)Nonviral Vectors and Formulations (France)Advances in RNAi--A Global Technology Assessment (Technical Insights), Research Developments in RNAi ApplicationsResearch in the Private SectorRNAi Candidate for Liver Cancer (Germany)Treat AMD and DR with RNAi (USA)C. elegans as an Animal Model for Human Diseases (Belgium)RNAi for Nonhuman Therapeutics (USA)Novel Nucleotide Chemistry enhances siRNA Therapeutics (Denmark)Genome Wide siRNA Screening (Germany)siRNA-Based SARS Virus Inhibitors (USA)siRNA Agent Slows Macular Degeneration In Animals (USA)Research in the Public SectorTargeTran siRNA Nanoparticle Technology (USA)RNAi Gene Therapy for HIV Infection (USA)Advances in RNAi--A Global Technology Assessment (Technical Insights), RNAi Sector--Technology AssessmentSector Trend AnalysisTechnology TrendsCorporate Collaborations (Part I)Corporate Collaborations (Part II)RNAi Technology Drivers and ChallengesTechnology DriversTechnology ChallengesAdvances in RNAi--A Global Technology Assessment (Technical Insights), Key Contacts and Noteworthy PatentsKey ContactsIndustry ContactsUniversity ContactsImportant PatentsPatents Part IPatents Part IIAdvances in RNAi--A Global Technology Assessment (Technical Insights), Frost & Sullivan 2004 Science and Technology AwardsExcellence in ResearchAward DescriptionAward RecipientExcellence in TechnologyAward DescriptionAward RecipientTechnology Innovation AwardAward DescriptionAward Recipient Advances in RNAi--A Global Technology Assessment (Technical Insights), Relevant Decision Support Database (DSD) TablesHealthcare ExpenditureGovernment Healthcare Expenditure (1999 to 2006)Private Healthcare Expenditure (1999 to 2006)Total Healthcare Expenditure (1999 to 2006)Percentage Healthcare Expenditure (1999 to 2006)Per Capita Healthcare Expenditure (1999 to 2006)Pharma R & D ExpenditurePharma R & D Expenditure (1999 to 2006)Percentage Pharma R&D Expenditure (1999 to 2006)Cancer Incidence and MortalityBreast Cancer Incidence (1999 to 2006)Breast Cancer Mortality (1999 to 2006)Liver Cancer Incidence (1999 to 2006)Liver Cancer Mortality (1999 to 2006)Cataract and DiabetesCataract Blindness (1999 to 2006)Cataract Surgeries (1999 to 2006)Diabetes Incidence (1999 to 2006)Diabetes Prevalence (1999 to 2006)




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Release Date : 29-Nov-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.